This invention relates generally to hydrocarbon oligomerization, and more particularly to a method of making hydrocarbons using cataloreactants.
Scientists have long sought efficient ways to convert methane and other alkanes into higher hydrocarbons, including light olefins and gasoline-range materials. Efficient processes could create value in a number of ways, including: facilitating the utilization of remotely located stranded natural gas through its conversion into more easily transportable liquid fuels and feedstocks, and allowing the use of inexpensive feedstocks (methane and other lower alkanes) for end products often made from higher alkanes, including ethylene and propylene.
U.S. Pat. Nos. 6,486,368, 6,472,572, 6,465,699, 6,465,696, and 6,462,243 disclose processes for converting alkanes into olefins, ethers, and alcohols. Many of the disclosed processes involve halogenation of an alkane, passing the halogenated products over a metal oxide to create products and metal halide, recovering the product(s), and regenerating the metal halide with oxygen or air to yield metal oxide and halogen for recycle to the process. Not described is alkane oligomerization: substantial coupling of the starting hydrocarbon to obtain product(s) of higher carbon number.
Several investigators have examined the use of halogenation for the production of higher hydrocarbons from methane. Representative patents include U.S. Pat. No. 4,513,092 (Chu), U.S. Pat. No. 4,769,504 (Noceti and Taylor), U.S. Pat. No. 5,087,786 (Nubel), and U.S. Pat. No. 6,452,058 (Schweitzer). As described in the Taylor patent: “Aromatic-rich, gasoline boiling range hydrocarbons [are made] from the lower alkanes, particularly from methane. The process is carried out in two stages. In the first, alkane is reacted with oxygen and hydrogen chloride over an oxyhydrochlorination catalyst such as copper chloride with minor proportions of potassium chloride and rare earth chloride. This produces an intermediate gaseous mixture containing water and chlorinated alkanes. The chlorinated alkanes are contacted with a crystalline aluminosilicate catalyst in the hydrogen or metal-promoted form to produce gasoline range hydrocarbons with a high proportion of aromatics and a small percentage of light hydrocarbons (C2-C4), as well as reforming the HCl. The light hydrocarbons can be recycled for further processing over the oxyhydrochlorination catalyst.” All of these techniques for making higher alkanes from C1 feedstocks suffer from the disadvantage that the hydrocarbon stream must be separated from an aqueous hydrohalic acid stream, and the hydrohalic acid stream must be recycled.
U.S. Pat. No. 4,795,843 (Tomotsu et al.) discloses a process for oligomerizing halomethanes to products including ethyl benzene, toluene, and xylenes, using silica polymorph or silicalite catalysts. The process does not incorporate reactive neutralization of hydrogen halide, and appears to suffer from slow kinetics.
In a process for halogenating hydrocarbons, Chang and Perkins noted trace amounts of oligomerization products in the presence of zeolites in U.S. Pat. No. 4,654,449. The oligomerization products were low in quantity, and generally halogenated.
U.S. Pat. No. 4,373,109 (Olah) discloses a process for converting heterosubstituted methanes, including methyl halides, by contacting such methanes with bifunctional acid-base catalysts at elevated temperatures, between 200 and 450 C, preferably between 250 and 375 C, to produce predominantly lower olefins, preferably ethylene and propylene. The catalysts of preference are those derived from halides, oxyhalides, oxides, sulfides or oxysulfides of transition metals of Groups IV, V, VI, VIII of the Periodic Table, such as tantalum, niobium, zirconium, tungsten, titanium, and chromium, deposited on acidic oxides and sulfides such as alumina, silica, zirconia or silica-alumina. Neither the use of solid oxide-based halogen recovery nor the formation of alcohols or ethers is disclosed. A related reference is “Ylide chemistry. 1. Bifunctional acid-base-catalyzed conversion of heterosubstituted methanes into ethylene and derived hydrocarbons. The onium-ylide mechanism of the C1→C2 conversion” by George A. Olah et al. (J. Am. Chem. Soc. 106, 2143 (1984)).
U.S. Pat. No. 3,894,107 (Butter, et al.) discloses improvements to a process for condensing halogenated hydrocarbons using zeolite catalysts. Notably absent is any discussion of solid oxide-based hydrogen halide neutralization.
Kochi has observed reductive coupling of alkyl halides when transition metal bromides are reacted with low-molecular weight Grignard reagents in THF or diethyl ether (Bulletin of the Chemical Society of Japan v. 44 1971 pp. 3063-73). Liquid phase chemistry, however, typically suffers from such disadvantages as the requirement of solvent, corrosion, and lower rates of reaction than gas-phase chemistry. In addition, such a process consumes energy required to produce the magnesium metal needed for the energetic and reducing Grignard reagents. This is not the same type of process as the dehydrohalogenative coupling and hydrogen halide neutralization we describe herein.
The present invention addresses the need for an efficient way to convert methane and other hydrocarbons into higher hydrocarbons. In one embodiment, a hydrocarbon having a carbon number Cn, where n≧2, is prepared by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a halogenating agent, thereby forming a halogenated hydrocarbon; allowing the halogenated hydrocarbon to contact a metal-oxygen cataloreactant, thereby forming a product hydrocarbon having an carbon number Cn, where n≧2; recovering the product hydrocarbon; and regenerating the cataloreactant. Often, a mixture of hydrocarbons is obtained, but careful selection of the reactant hydrocarbon, halogenating agent, metal-oxygen cataloreactant, and reaction conditions allow a tailored approach to hydrocarbon product formation. Methane (i.e., natural gas) as well as other light hydrocarbons, e.g., C2 to C6 hydrocarbons, are envisioned as preferred feedstocks.
Although laboratory observations have thus far focused on methane oligomerization with detection of ethylene, propylene, butenes and aromatics, the invention contemplates the use of feedstocks having carbon numbers as high as C10.
The present invention exploits the discovery that metal-oxygen compounds, such as mixed metal oxides, particularly metal oxide-impregnated zeolites, facilitate hydrocarbon oligomerization. According to one aspect of the invention, a hydrocarbon having a carbon number Cn, where n≧2, is formed by (i) forming a halogenated hydrocarbon by allowing a reactant hydrocarbon having a carbon number Cm, where m<n, to react with a halogenating agent; (ii) forming a product hydrocarbon having a carbon number Cn, where n≧2, by allowing the halogenated hydrocarbon to contact a metal-oxygen cataloreactant; (iii) recovering the product hydrocarbon; and (iv) regenerating the cataloreactant.
More generally, the method entails the steps of halogenation, oligomerization, product recovery, and cataloreactant regeneration. The halogenated products may be separated from the unreacted (non-halogenated) hydrocarbon either before or after reaction with the metal-oxygen cataloreactant. Neutralization of any hydrohalic acid formed during the synthesis is advantageously accomplished concommitantly with carbon-carbon coupling and/or cataloreactant regeneration. Preferably, the process is an integrated one and takes place, for example, in a zone reactor, as described, for example, in U.S. Pat. No. 6,525,230 (Grosso), the entire contents of which is incorporated by reference herein. Thus, halogenation of methane or other hydrocarbons occurs within one zone of the reactor, and is followed by a condensation step in which the liberated hydrohalic acid is adsorbed within the same bifunctional material that catalyzes condensation of the halogenated hydrocarbon. Hydrocarbon oligomerization (defined as carbon-carbon coupling) takes place within this zone of the reactor and yields product hydrocarbons which, in general, will have carbon numbers ranging from C2 to C20, and may include alkanes, alkenes, alkynes, and/or aromatics. Treatment with air or oxygen liberates halogen for use in subsequent halogenation steps, and regenerates the cataloreactant material for subsequent condensation or metathesis. Advantageously, the need for recycling/recovering corrosive, aqueous hydrohalic acid is avoided because regeneration and recovery takes place in situ.
Higher hydrocarbon synthesis begins with a hydrocarbon feedstock: one or more reactant hydrocarbons, each having, independently, a carbon number Cm, where m<n, Cn being the carbon number of the target hydrocarbon(s). Non-limiting examples of reactant hydrocarbons include methane, ethane, propane, etc., with natural gas (predominately methane, but often including small amounts of C2 and higher species) being preferred. In general, the starting hydrocarbon has a carbon number between 1 and 10. Mixtures of hydrocarbons may also be used.
The reactant hydrocarbons are allowed to react with a halogenating agent. Non-limiting examples include molecular halogen (e.g., bromine, chlorine, etc.), alkyl halides (e.g., dibromomethane, bromoform, carbon tetrabromide), and condensed halides, such as metal bromides, which may be present as a solid, liquid, supported, or unsupported material.
Molecular halogens are preferred, with bromine (Br2) being most preferred. Bromine is a liquid at room temperature, less reactive than chlorine and fluorine, and easy to handle. Bromine also has favorable energetics.
The reduction potential of bromine to bromide is 1.07 V vs. NHE, while that of oxygen to water is 1.23 V. A broad range of metal bromides may release bromine upon treatment with oxygen. At the same time, alkane bromination and subsequent alkyl bromide coupling and HBr neutralization are only mildly exothermic, but spontaneous enough to go to completion. Water and coupled hydrocarbons are the only fluid products. The same is not true with chlorine as mediator, for which HCl is a major component of the product stream. Hydrogen chloride production requires separation, drying, and recycling, which is costly. In short, the thermochemistry of metal bromide-mediated alkane partial oxidiation is well-suited for efficient and inexpensive plant operation.
Halogenation of the reactant hydrocarbon may proceed in a number of ways, depending in part on the desired product(s) and in part on the feed. In one embodiment, an alkane is halogenated with molecular halogen using heat, light, or other electromagnetic radiation to drive the reaction, with heat being preferred. There is some benefit in having all steps—halogenation, oligomerization, and regeneration (described below)—occur at roughly the same temperature. As typical temperatures for methanol to olefin (MTO) and methanol to gasoline (MTG) processes, temperatures of from 375 to 450° C. are utilized, with the range being important, if not critical. For the carbon-carbon coupling process described herein, an ideal temperature range, where all steps occur at roughly the same temperature, is 450 to 550° C. Alternatively, individual reaction steps might be carried out at temperatures above or below this range.
Halogenation preferably occurs at a pressure between 0.1 and 200 atm, for the subsequent carbon-carbon step. Low pressure favors less carbon-carbon coupling (i.e., a smaller average molecular weight of product), while high pressure favors higher coupling. Processes for light olefins are likely to run at the same 60 to 200 psia that methanol to olefin (MTO) processes are run at, although higher pressures may alternatively be utilized. For production of gasoline-range molecules, pressures around 350 psia, as used in methanol to gasoline (MTG) processes, are envisioned. As a practical matter, running below atmospheric (more conservatively, below 2 psia) or above 100 atm is unlikely.
When molecular halogen is used as the halogenating agent, halogenation ideally is carried out at an alkane:halogen ratio of between 1:10 and about 100:1, on a volume by volume basis. At alkane:halogen ratios of less than 1:10 (i.e., more halogen), multi-halogenated hydrocarbons will be formed, typically leading to complete oxidation (i.e., CO2) upon subsequent contact with the metal-oxygen cataloreactant. At alkane:halogen ratios higher than 100:1, the conversion to a halogenated hydrocarbon will be too low, perhaps 1% or less, and it is nearly impossible to imagine an economical process at such conversion levels. (30-60% conversion are more likely lower limits).
Altering the ratio of halogen to alkane or other hydrocarbon feedstock may have a marked impact on product distribution. For example, one may choose to control the degree of halogenation in order to reduce aromatic formation in the production of lower olefins or fuels. A second example is minimizing formation of highly halogenated methane in order to reduce the formation of alkynes.
A key feature of the invention is the use of a metal-oxygen cataloreactant, which facilitates carbon-carbon coupling, i.e., hydrocarbon oligomerization. The term “metal-oxygen cataloreactant” is used herein to refer to a cataloreactant material containing both metal and oxygen. While not bound by theory, it is believed that the material catalyzes carbon-carbon coupling via hydrogen halide (e.g., HBr) elimination and alkyldiene insertion into cationically activated C—H and possibly C—C bonds. The cataloreactant also acts as a halogen release and sequestering agent, and offers the possibility of obtaining a tunable coupling product distribution, including the ability to produce oxygenates if desired, while simultaneously trapping and recovering halogen, emitting only water as a byproduct. Treatment with air or oxygen regenerates the cataloreactant.
Nonlimiting examples of metal-oxygen cataloreactants include zeolites, doped zeolites, metal oxides, mixed metal oxides, metal oxide-impregnated zeolites, and similar materials, as well as mixtures of such materials. Nonlimiting examples of dopants include calcium and magnesium, and their oxides and/or hydroxides.
Zeolites are available from a variety of sources, including Zeolyst International (Valley Forge, Pa.). Specific examples include doped-ZSM-5 and doped mordenite (where, e.g., calcium and/or magnesium are the dopants).
Shifting the properties of the zeolite or zeolite component of a zeolite/metal oxide composite is also expected to shift product distribution. Pore size and acidity are particularly expected to be important. Acidity may be used to control chain length and functionality, and pore size may control chain length and functionality. Zeolites of particular pore-size may selectively produce benzene, toluene, para-xylene, ortho-xylene, meta-xylene, mixed xylenes, ethyl benzene, styrene, linear alkyl benzene, or other aromatic products. The use of pore size is not limited to aromatic products.
In one embodiment of the invention, a metal oxide/zeolite composite is prepared by mixing a zeolite with a metal nitrate (e.g., calcium nitrate) or hydrated species thereof.
After oligomerization, the metal-oxygen cataloreactant is regenerated by treatment with air or oxygen, typically at a temperature of from 200 to 900° C. This converts metal halide species into metal-oxygen species.
A number of variables, including feed composition, feed location in the reactor, temperature, pressure, metal oxide composition, and reactor residence time may alter the product distribution. Production of alkanes, olefins and aromatics from methane has been detected and confirmed. Also expected is the ability to produce alkanes and olefins of particular branching (including mono-methyl branched alcohols), alcohols, diols, ethers, halogenated hydrocarbons, aromatics including benzene, styrene, ethyl benzene, toluene, xylenes, and linear alkyl benzenes, and hydrocarbons suitable for fuels such as gasoline, diesel, and jet fuel.
Control of the feed composition can control the product distribution. First, hydrogen halide produced in the halogenation may be neutralized (to form water or alcohol) with the same metal-oxygen compound producing the hydrocarbon product(s), or with a separate metal-oxygen compound in a distinct reactor. Shifting the hydrogen halide neutralization location may shift the product distribution, including functionality, chain length, and branching. For example, concurrent neutralization and product formation may be expected to drive the production of alcohols, which may or may not undergo further reactions such as coupling or dehydration. Second, water addition to the feed may shift product distribution. In particular, the addition of water may favor alcohol products. The addition of water may also control degree and type of branching and chain length. Third, hydrogen addition may alter the product distribution. Hydrogen may increase alkanes at the expense of other functionalities, something particularly useful for producing fuels. Hydrogen may also reduce coking and help control the chain length and branching.
It will also be appreciated that carbon-carbon oligomerization may proceed by a number of pathways. Even single-hydrocarbon feedstocks may yield more than one product. On the other hand, in one embodiment of the invention, controlled halogentation is used to produce predominately one isomer in favor of another (e.g., selective formation of 1-butene or 2-butene). Mixed feedstocks, such as raw natural gas, may give rise to oligomerization of multiple halogenated hydrocarbons (e.g., ethyl halide, dihaloethane, methyl halide, methyl dihalide, propyl halide, propyl dihalide, etc.). Indeed, in one embodiment of the invention, an alkyl halide is purposefully introduced to create desired branched products. An example would be oligomerization of methyl halide (from methane) with ethyl halide or a higher alkyl halide to produce, selectively, methyl, ethyl, propyl, isopropyl, or tertiary butyl (or other) branching. Another example might be the synthesis of styrene from ethyl halide, methyl halide, and dihalomethane.
In one embodiment of the invention, the reaction of halogenated hydrocarbon with a metal-oxygen cataloreactant takes place in a fluidized bed. Alternatively, a fixed bed is employed. Different alkyl halides may be introduced at different locations in the reactor. One example is the introduction of methyl halides at one location in a reactor to produce benzene, to which ethyl halides are added, producing styrene or ethyl benzene. Another example is the introduction of methyl halides at one location in a reactor to produce benzene, to which alkyl halides are added, producing linear alkyl benzene.
Product separation is accomplished by any suitable method. Nonlimiting examples include distillation, adsorption, and extraction. Product(s) may be recovered from the solid by stripping with steam, carbon dioxide, or other means.
The following are nonlimiting examples of the invention:
Metal Oxide/Zeolite composite MZ1 was prepared as follows: A solid mixture of a ZSM-5-type zeolite (Zeolyst CBV 8014, Si/Al ratio=80, 10 g, 170 mmoles SiO2) and CaNO3 nonahydrate (9 g, =34 mmoles Ca) was prepared and water was added to incipient wetness. After CaNO3 dissolution and stirring, the slurry was dried and calcined in sequence at 115 C (overnight) and 500 C (overnight), respectively, in air.
Methane at 15 psia was bubbled through bromine at 1° C. at a rate of 5 cc/min. The resulting stream of bromine and methane (1:10 by mole) was passed through a small diameter bromination reactor at 450° C. (1000 h−1) and the mixture of CH4-xBrx (x=0, 1, 2, 3) passed into a reactor containing 5 g of metal oxide/zeolite composite MZ1 (400 C). The output stream from the second reactor contained no brominated products. Based on the methane consumed in the bromination reactor, 10% ethylene, 31% propylene, 3% propane, and 1% butanes/butenes were detected; 65% overall. Trace amounts of C6 species were also detected. After reaction for 5 hours, during which the stream output did not change from the distribution described above, the methane stream was discontinued and the reactor was purged with helium at 5 cc/min for 10 minutes. After He purge, a flow of O2 (2 cc/min) into the second reactor was initiated at 525 C to regenerate the metal oxide from the metal bromide of the partially spent composite. Initially only water and CO2 were observed as products, but abruptly the stream contents changed to Br2 and unreacted O2. After 1 hour, the O2 purge was discontinued and the reactor was again purged with helium. The caustic trap used during regeneration was tested for CO3−2 and 1.0 mmol was found, representing 24% of the converted carbon. The remainder of carbon was found to be higher boiling volatile aromatics (mostly toluene, xylenes and mesitylenes). A second cycle of bromomethanes condensation as described above was initiated at 400° C. and the product distribution was found to be identical to the first run. Three more cycles of condensation/neutralization/regeneration produced the same output of higher hydrocarbons.
A doped mordenite (Zeolyst CBV 21A, doped with both Ca and Mg) (5 g) was prepared according to Example 1, and used as the cataloreactant in a hydrocarbon synthesis substantially similar to that described above in Example 2. The product output was 30% ethylene, 5% ethane, 10% propylene, 3% propane, 5% butanes/butenes. Multiple runs and cataloreactant regeneration established reproducibility.
The invention has been described by reference to various examples and preferred embodiments, but is not limited thereto. Other modifications and substitutions can be made without departing from the scope of the invention. For example, the oligomerization processes described herein are also intended to encompass halogenation of olefin feedstocks using a hydrogen halide (e.g., HBr) or molecular halogen; halogenation of acetylenes (alkynes) using hydrogen halide or molecular halogen; halogenation of alcohols or ethers using hydrogen halide or molecular halogen; and halogenation of alkanes using molecular halogen and a catalyst that controls the halogenation. Specifically, the catalyst may control one or both of the degree of halogenation (number of halogens per molecule) and the position of halogenation (e.g. terminal vs. internal halogenation for a long chain alkane). Other modifications may be made as well. The invention is limited only by the appended claims and equivalents thereof.
This application is a continuation of U.S. patent application Ser. No. 10/893,418, filed Jul. 15, 2004, now abandoned which claims the benefit of U.S. Provisional Patent Application No. 60/487,364, filed Jul. 15, 2003. The disclosures of both applications are incorporated by reference herein as if set forth in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
2168260 | Heisel et al. | Aug 1939 | A |
2246082 | Vaughan et al. | Jun 1941 | A |
2488083 | Gorin et al. | Nov 1949 | A |
2677598 | Crummett et al. | May 1954 | A |
2941014 | Rothweiler et al. | Jun 1960 | A |
3076784 | Huermann et al. | Feb 1963 | A |
3172915 | Borkowski et al. | Mar 1965 | A |
3246043 | Rosset et al. | Apr 1966 | A |
3294846 | Livak et al. | Dec 1966 | A |
3310380 | Lester | Mar 1967 | A |
3346340 | Louvar et al. | Oct 1967 | A |
3353916 | Lester | Nov 1967 | A |
3353919 | Stockman | Nov 1967 | A |
3496242 | Berkowitz et al. | Feb 1970 | A |
3562321 | Borkowski et al. | Feb 1971 | A |
3598876 | Bloch | Aug 1971 | A |
3657367 | Blake et al. | Apr 1972 | A |
3670037 | Dugan | Jun 1972 | A |
3673264 | Kuhn | Jun 1972 | A |
3679758 | Schneider | Jul 1972 | A |
3702886 | Argauer et al. | Nov 1972 | A |
3705196 | Turner | Dec 1972 | A |
3799997 | Schmerling | Mar 1974 | A |
3865886 | Schindler et al. | Feb 1975 | A |
3876715 | McNulty et al. | Apr 1975 | A |
3879473 | Stapp | Apr 1975 | A |
3879480 | Riegel et al. | Apr 1975 | A |
3883651 | Woitun et al. | May 1975 | A |
3886287 | Kobayashi et al. | May 1975 | A |
3894103 | Chang et al. | Jul 1975 | A |
3894104 | Chang et al. | Jul 1975 | A |
3894105 | Chang et al. | Jul 1975 | A |
3894107 | Butter et al. | Jul 1975 | A |
3907917 | Forth | Sep 1975 | A |
3919336 | Kurtz | Nov 1975 | A |
3920764 | Riegel et al. | Nov 1975 | A |
3923913 | Antonini et al. | Dec 1975 | A |
3928483 | Chang et al. | Dec 1975 | A |
3965205 | Garwood et al. | Jun 1976 | A |
3974062 | Owen et al. | Aug 1976 | A |
3987119 | Kurtz et al. | Oct 1976 | A |
3992466 | Plank et al. | Nov 1976 | A |
4006169 | Anderson et al. | Feb 1977 | A |
4011278 | Plank et al. | Mar 1977 | A |
4025571 | Lago | May 1977 | A |
4025572 | Lago | May 1977 | A |
4025575 | Chang et al. | May 1977 | A |
4025576 | Chang et al. | May 1977 | A |
4035285 | Owen et al. | Jul 1977 | A |
4035430 | Dwyer et al. | Jul 1977 | A |
4039600 | Chang | Aug 1977 | A |
4044061 | Chang et al. | Aug 1977 | A |
4046825 | Owen et al. | Sep 1977 | A |
4049734 | Garwood et al. | Sep 1977 | A |
4052471 | Pearsall | Oct 1977 | A |
4052472 | Given et al. | Oct 1977 | A |
4058576 | Chang et al. | Nov 1977 | A |
4060568 | Rodewald | Nov 1977 | A |
4071753 | Fulenwider et al. | Jan 1978 | A |
4072733 | Hargis et al. | Feb 1978 | A |
4087475 | Jordan | May 1978 | A |
4088706 | Kaeding | May 1978 | A |
4092368 | Smith | May 1978 | A |
4110180 | Nidola et al. | Aug 1978 | A |
4117251 | Kaufhold et al. | Sep 1978 | A |
4129604 | Tsao | Dec 1978 | A |
4133838 | Pearson | Jan 1979 | A |
4133966 | Pretzer et al. | Jan 1979 | A |
4138440 | Chang et al. | Feb 1979 | A |
4156698 | Dwyer et al. | May 1979 | A |
4169862 | Eden | Oct 1979 | A |
4172099 | Severino | Oct 1979 | A |
4187255 | Dodd | Feb 1980 | A |
4194990 | Pieters et al. | Mar 1980 | A |
4197420 | Ferraris et al. | Apr 1980 | A |
4219680 | Konig et al. | Aug 1980 | A |
4249031 | Drent et al. | Feb 1981 | A |
4270929 | Dang Vu et al. | Jun 1981 | A |
4272338 | Lynch et al. | Jun 1981 | A |
4282159 | Davidson et al. | Aug 1981 | A |
4300005 | Li | Nov 1981 | A |
4300009 | Haag et al. | Nov 1981 | A |
4301253 | Warren | Nov 1981 | A |
4302619 | Gross et al. | Nov 1981 | A |
4307261 | Beard, Jr. et al. | Dec 1981 | A |
4308403 | Knifton | Dec 1981 | A |
4311865 | Chen et al. | Jan 1982 | A |
4317800 | Sloterdijk et al. | Mar 1982 | A |
4317934 | Seemuth | Mar 1982 | A |
4317943 | Knifton | Mar 1982 | A |
4320241 | Frankiewicz | Mar 1982 | A |
4333852 | Warren | Jun 1982 | A |
4347391 | Campbell | Aug 1982 | A |
4350511 | Holmes et al. | Sep 1982 | A |
4371716 | Paxson et al. | Feb 1983 | A |
4373109 | Olah | Feb 1983 | A |
4376019 | Gamlen et al. | Mar 1983 | A |
4380682 | Leitert et al. | Apr 1983 | A |
4384159 | Diesen | May 1983 | A |
4389391 | Dunn | Jun 1983 | A |
4410714 | Apanel | Oct 1983 | A |
4412086 | Beard, Jr. et al. | Oct 1983 | A |
4418236 | Cornelius et al. | Nov 1983 | A |
4431856 | Daviduk et al. | Feb 1984 | A |
4433189 | Young | Feb 1984 | A |
4433192 | Olah | Feb 1984 | A |
4439409 | Puppe et al. | Mar 1984 | A |
4440871 | Lok et al. | Apr 1984 | A |
4443620 | Gelbein et al. | Apr 1984 | A |
4462814 | Holmes et al. | Jul 1984 | A |
4465884 | Degnan et al. | Aug 1984 | A |
4465893 | Olah | Aug 1984 | A |
4467130 | Olah | Aug 1984 | A |
4467133 | Chang et al. | Aug 1984 | A |
4489210 | Judat et al. | Dec 1984 | A |
4489211 | Ogura et al. | Dec 1984 | A |
4492657 | Heiss | Jan 1985 | A |
4496752 | Gelbein et al. | Jan 1985 | A |
4497967 | Wan | Feb 1985 | A |
4499314 | Seddon et al. | Feb 1985 | A |
4506105 | Kaufhold | Mar 1985 | A |
4509955 | Hayashi | Apr 1985 | A |
4513092 | Chu et al. | Apr 1985 | A |
4513164 | Olah | Apr 1985 | A |
4523040 | Olah | Jun 1985 | A |
4524227 | Fowles et al. | Jun 1985 | A |
4524228 | Fowles et al. | Jun 1985 | A |
4524231 | Fowles et al. | Jun 1985 | A |
4538014 | Miale et al. | Aug 1985 | A |
4538015 | Miale et al. | Aug 1985 | A |
4540826 | Banasiak et al. | Sep 1985 | A |
4543434 | Chang | Sep 1985 | A |
4544781 | Chao et al. | Oct 1985 | A |
4547612 | Tabak | Oct 1985 | A |
4550217 | Graziani et al. | Oct 1985 | A |
4550218 | Chu | Oct 1985 | A |
4568660 | Klosiewicz | Feb 1986 | A |
4579977 | Drake | Apr 1986 | A |
4579992 | Kaufhold et al. | Apr 1986 | A |
4579996 | Font Freide et al. | Apr 1986 | A |
4587375 | Debras et al. | May 1986 | A |
4588835 | Torii et al. | May 1986 | A |
4590310 | Townsend et al. | May 1986 | A |
4599474 | Devries et al. | Jul 1986 | A |
4605796 | Isogai et al. | Aug 1986 | A |
4605803 | Chang et al. | Aug 1986 | A |
4621161 | Shihabi | Nov 1986 | A |
4621164 | Chang et al. | Nov 1986 | A |
4633027 | Owen et al. | Dec 1986 | A |
4634800 | Withers, Jr. et al. | Jan 1987 | A |
4642403 | Hyde et al. | Feb 1987 | A |
4642404 | Shihabi | Feb 1987 | A |
4652688 | Brophy et al. | Mar 1987 | A |
4654449 | Chang et al. | Mar 1987 | A |
4655893 | Beale | Apr 1987 | A |
4658073 | Tabak | Apr 1987 | A |
4658077 | Kolts et al. | Apr 1987 | A |
4665259 | Brazdil et al. | May 1987 | A |
4665267 | Barri | May 1987 | A |
4665270 | Brophy et al. | May 1987 | A |
4675410 | Feitler et al. | Jun 1987 | A |
4690903 | Chen et al. | Sep 1987 | A |
4695663 | Hall et al. | Sep 1987 | A |
4696985 | Martin | Sep 1987 | A |
4704488 | Devries et al. | Nov 1987 | A |
4704493 | Devries et al. | Nov 1987 | A |
4709108 | Devries et al. | Nov 1987 | A |
4720600 | Beech, Jr. et al. | Jan 1988 | A |
4720602 | Chu | Jan 1988 | A |
4724275 | Hinnenkamp et al. | Feb 1988 | A |
4735747 | Ollivier et al. | Apr 1988 | A |
4737594 | Olah | Apr 1988 | A |
4748013 | Saito et al. | May 1988 | A |
4769504 | Noceti et al. | Sep 1988 | A |
4774216 | Kolts et al. | Sep 1988 | A |
4775462 | Imai et al. | Oct 1988 | A |
4777321 | Harandi et al. | Oct 1988 | A |
4781733 | Babcock et al. | Nov 1988 | A |
4783566 | Kocal et al. | Nov 1988 | A |
4788369 | Marsh et al. | Nov 1988 | A |
4788377 | Chang et al. | Nov 1988 | A |
4792642 | Rule et al. | Dec 1988 | A |
4795732 | Barri | Jan 1989 | A |
4795737 | Rule et al. | Jan 1989 | A |
4795843 | Imai et al. | Jan 1989 | A |
4795848 | Teller et al. | Jan 1989 | A |
4804797 | Minet et al. | Feb 1989 | A |
4804800 | Bortinger et al. | Feb 1989 | A |
4808763 | Shum | Feb 1989 | A |
4814527 | Diesen | Mar 1989 | A |
4814532 | Yoshida et al. | Mar 1989 | A |
4814535 | Yurchak | Mar 1989 | A |
4814536 | Yuchak | Mar 1989 | A |
4849562 | Buhs et al. | Jul 1989 | A |
4849573 | Kaefing | Jul 1989 | A |
4851602 | Harandi et al. | Jul 1989 | A |
4851606 | Ragonese et al. | Jul 1989 | A |
4886925 | Harandi | Dec 1989 | A |
4886932 | Leyshon | Dec 1989 | A |
4891463 | Chu | Jan 1990 | A |
4895995 | James, Jr. et al. | Jan 1990 | A |
4899000 | Stauffer | Feb 1990 | A |
4899001 | Kalnes et al. | Feb 1990 | A |
4899002 | Harandi et al. | Feb 1990 | A |
4902842 | Kalnes et al. | Feb 1990 | A |
4925995 | Robschlager | May 1990 | A |
4929781 | James, Jr. et al. | May 1990 | A |
4939310 | Wade | Jul 1990 | A |
4939311 | Washecheck et al. | Jul 1990 | A |
4945175 | Hobbs et al. | Jul 1990 | A |
4950811 | Doussain et al. | Aug 1990 | A |
4950822 | Dileo et al. | Aug 1990 | A |
4956521 | Volles | Sep 1990 | A |
4962252 | Wade | Oct 1990 | A |
4973776 | Allenger et al. | Nov 1990 | A |
4973786 | Karra | Nov 1990 | A |
4982024 | Lin et al. | Jan 1991 | A |
4982041 | Campbell | Jan 1991 | A |
4988660 | Campbell | Jan 1991 | A |
4990696 | Stauffer | Feb 1991 | A |
4990711 | Chen et al. | Feb 1991 | A |
5001293 | Nubel et al. | Mar 1991 | A |
5004847 | Beaver et al. | Apr 1991 | A |
5013424 | James, Jr. et al. | May 1991 | A |
5013793 | Wang et al. | May 1991 | A |
5019652 | Taylor et al. | May 1991 | A |
5026934 | Bains et al. | Jun 1991 | A |
5026937 | Bricker | Jun 1991 | A |
5026944 | Allenger et al. | Jun 1991 | A |
5034566 | Ishino et al. | Jul 1991 | A |
5043502 | Martindale et al. | Aug 1991 | A |
5055235 | Brackenridge et al. | Oct 1991 | A |
5055633 | Volles | Oct 1991 | A |
5055634 | Volles | Oct 1991 | A |
5059744 | Harandi et al. | Oct 1991 | A |
5068478 | Miller et al. | Nov 1991 | A |
5071449 | Sircar | Dec 1991 | A |
5071815 | Wallace | Dec 1991 | A |
5073656 | Chafin et al. | Dec 1991 | A |
5073657 | Warren | Dec 1991 | A |
5082473 | Keefer | Jan 1992 | A |
5082816 | Teller et al. | Jan 1992 | A |
5085674 | Leavitt | Feb 1992 | A |
5087779 | Nubel et al. | Feb 1992 | A |
5087786 | Nubel et al. | Feb 1992 | A |
5087787 | Kimble et al. | Feb 1992 | A |
5093542 | Gaffney | Mar 1992 | A |
5096469 | Keefer | Mar 1992 | A |
5097083 | Stauffer | Mar 1992 | A |
5099084 | Stauffer | Mar 1992 | A |
5105045 | Kimble et al. | Apr 1992 | A |
5105046 | Washecheck | Apr 1992 | A |
5107032 | Erb et al. | Apr 1992 | A |
5107051 | Pannell | Apr 1992 | A |
5107061 | Ou et al. | Apr 1992 | A |
5108579 | Casci | Apr 1992 | A |
5118899 | Kimble et al. | Jun 1992 | A |
5120332 | Wells | Jun 1992 | A |
5132343 | Zwecker et al. | Jul 1992 | A |
5138112 | Gosling et al. | Aug 1992 | A |
5139991 | Taylor et al. | Aug 1992 | A |
5146027 | Gaffney | Sep 1992 | A |
5157189 | Karra | Oct 1992 | A |
5160502 | Kimble et al. | Nov 1992 | A |
5166452 | Gradl et al. | Nov 1992 | A |
5175382 | Hebgen et al. | Dec 1992 | A |
5178748 | Casci et al. | Jan 1993 | A |
5185479 | Stauffer | Feb 1993 | A |
5188725 | Harandi | Feb 1993 | A |
5191142 | Marshall et al. | Mar 1993 | A |
5194244 | Brownscombe et al. | Mar 1993 | A |
5202506 | Kirchner et al. | Apr 1993 | A |
5202511 | Salinas, III et al. | Apr 1993 | A |
5210357 | Kolts et al. | May 1993 | A |
5215648 | Zones et al. | Jun 1993 | A |
5223471 | Washecheck | Jun 1993 | A |
5228888 | Gmelin et al. | Jul 1993 | A |
5233113 | Periana et al. | Aug 1993 | A |
5237115 | Makovec et al. | Aug 1993 | A |
5243098 | Miller et al. | Sep 1993 | A |
5243114 | Johnson et al. | Sep 1993 | A |
5245109 | Kaminsky et al. | Sep 1993 | A |
5254772 | Dukat et al. | Oct 1993 | A |
5254790 | Thomas et al. | Oct 1993 | A |
5264635 | Le et al. | Nov 1993 | A |
5268518 | West et al. | Dec 1993 | A |
5276226 | Horvath et al. | Jan 1994 | A |
5276240 | Timmons et al. | Jan 1994 | A |
5276242 | Wu | Jan 1994 | A |
5284990 | Peterson et al. | Feb 1994 | A |
5300126 | Brown et al. | Apr 1994 | A |
5306855 | Periana et al. | Apr 1994 | A |
5316995 | Kaminsky et al. | May 1994 | A |
5319132 | Ozawa et al. | Jun 1994 | A |
5334777 | Miller et al. | Aug 1994 | A |
5345021 | Casci et al. | Sep 1994 | A |
5354916 | Horvath et al. | Oct 1994 | A |
5354931 | Jan et al. | Oct 1994 | A |
5366949 | Schubert | Nov 1994 | A |
5371313 | Ostrowicki | Dec 1994 | A |
5382704 | Krespan et al. | Jan 1995 | A |
5382743 | Beech, Jr. et al. | Jan 1995 | A |
5382744 | Abbott et al. | Jan 1995 | A |
5385718 | Casci et al. | Jan 1995 | A |
5395981 | Marker | Mar 1995 | A |
5399258 | Fletcher et al. | Mar 1995 | A |
5401890 | Parks | Mar 1995 | A |
5401894 | Brasier et al. | Mar 1995 | A |
5406017 | Withers, Jr. | Apr 1995 | A |
5414173 | Garces et al. | May 1995 | A |
5430210 | Grasselli et al. | Jul 1995 | A |
5430214 | Smith et al. | Jul 1995 | A |
5430219 | Sanfilippo et al. | Jul 1995 | A |
5436378 | Masini et al. | Jul 1995 | A |
5444168 | Brown | Aug 1995 | A |
5446234 | Casci et al. | Aug 1995 | A |
5453557 | Harley et al. | Sep 1995 | A |
5456822 | Marcilly et al. | Oct 1995 | A |
5457255 | Kumata et al. | Oct 1995 | A |
5464799 | Casci et al. | Nov 1995 | A |
5465699 | Voigt | Nov 1995 | A |
5470377 | Whitlock | Nov 1995 | A |
5480629 | Thompson et al. | Jan 1996 | A |
5486627 | Quarderer et al. | Jan 1996 | A |
5489719 | Le et al. | Feb 1996 | A |
5489727 | Randolph et al. | Feb 1996 | A |
5500297 | Thompson et al. | Mar 1996 | A |
5510525 | Sen et al. | Apr 1996 | A |
5523503 | Funk et al. | Jun 1996 | A |
5525230 | Wrigley et al. | Jun 1996 | A |
5538540 | Whitlock | Jul 1996 | A |
5563313 | Chung et al. | Oct 1996 | A |
5565092 | Pannell et al. | Oct 1996 | A |
5565616 | Li et al. | Oct 1996 | A |
5571762 | Clerici et al. | Nov 1996 | A |
5571885 | Chung et al. | Nov 1996 | A |
5599381 | Whitlock | Feb 1997 | A |
5600043 | Johnston et al. | Feb 1997 | A |
5600045 | Van Der Aalst et al. | Feb 1997 | A |
5609654 | Le et al. | Mar 1997 | A |
5633419 | Spencer et al. | May 1997 | A |
5639930 | Penick | Jun 1997 | A |
5653956 | Zones | Aug 1997 | A |
5656149 | Zones et al. | Aug 1997 | A |
5661097 | Spencer et al. | Aug 1997 | A |
5663465 | Clegg et al. | Sep 1997 | A |
5663474 | Pham et al. | Sep 1997 | A |
5675046 | Ohno et al. | Oct 1997 | A |
5675052 | Menon et al. | Oct 1997 | A |
5679134 | Brugerolle et al. | Oct 1997 | A |
5679879 | Mercier et al. | Oct 1997 | A |
5684213 | Nemphos et al. | Nov 1997 | A |
5693191 | Pividal et al. | Dec 1997 | A |
5695890 | Thompson et al. | Dec 1997 | A |
5698747 | Godwin et al. | Dec 1997 | A |
5705712 | Frey et al. | Jan 1998 | A |
5705728 | Viswanathan et al. | Jan 1998 | A |
5705729 | Huang | Jan 1998 | A |
5708246 | Camaioni et al. | Jan 1998 | A |
5720858 | Noceti et al. | Feb 1998 | A |
5728897 | Buysch et al. | Mar 1998 | A |
5728905 | Clegg et al. | Mar 1998 | A |
5734073 | Chambers et al. | Mar 1998 | A |
5741949 | Mack | Apr 1998 | A |
5744669 | Kalnes et al. | Apr 1998 | A |
5750801 | Buysch et al. | May 1998 | A |
5770175 | Zones | Jun 1998 | A |
5776871 | Cothran et al. | Jul 1998 | A |
5780703 | Chang et al. | Jul 1998 | A |
5798314 | Spencer et al. | Aug 1998 | A |
5814715 | Chen et al. | Sep 1998 | A |
5817904 | Vic et al. | Oct 1998 | A |
5821394 | Schoebrechts et al. | Oct 1998 | A |
5959170 | Withers | Sep 1999 | A |
5968236 | Bassine | Oct 1999 | A |
5969195 | Stabel et al. | Oct 1999 | A |
5998679 | Miller | Dec 1999 | A |
6056804 | Keefer et al. | May 2000 | A |
6068679 | Zheng | May 2000 | A |
6320085 | Arvai et al. | Nov 2001 | B1 |
6368490 | Gestermann | Apr 2002 | B1 |
6403840 | Zhou et al. | Jun 2002 | B1 |
6406523 | Connor et al. | Jun 2002 | B1 |
6452058 | Schweizer et al. | Sep 2002 | B1 |
6462243 | Zhou et al. | Oct 2002 | B1 |
6465696 | Zhou et al. | Oct 2002 | B1 |
6465699 | Grosso | Oct 2002 | B1 |
6472572 | Zhou et al. | Oct 2002 | B1 |
6486368 | Zhou et al. | Nov 2002 | B1 |
6511526 | Jagger et al. | Jan 2003 | B2 |
6514319 | Keefer et al. | Feb 2003 | B2 |
6525230 | Grosso | Feb 2003 | B2 |
6641644 | Jagger et al. | Nov 2003 | B2 |
6672572 | Werlen | Jan 2004 | B2 |
6692626 | Keefer et al. | Feb 2004 | B2 |
6713087 | Tracy et al. | Mar 2004 | B2 |
6713655 | Yilmaz et al. | Mar 2004 | B2 |
RE38493 | Keefer et al. | Apr 2004 | E |
6740146 | Simonds | May 2004 | B2 |
6866950 | Connor et al. | Mar 2005 | B2 |
6902602 | Keefer et al. | Jun 2005 | B2 |
6921597 | Keefer et al. | Jul 2005 | B2 |
6956140 | Ehrenfeld | Oct 2005 | B2 |
6958306 | Holtcamp | Oct 2005 | B2 |
6984763 | Schweizer et al. | Jan 2006 | B2 |
7001872 | Pyecroft et al. | Feb 2006 | B2 |
7002050 | Santiago Fernandez et al. | Feb 2006 | B2 |
7011811 | Elomari | Mar 2006 | B2 |
7019182 | Grosso | Mar 2006 | B2 |
7026145 | Mizrahi et al. | Apr 2006 | B2 |
7026519 | Santiago Fernandez et al. | Apr 2006 | B2 |
7037358 | Babicki et al. | May 2006 | B2 |
7045670 | Johnson et al. | May 2006 | B2 |
7049388 | Boriack et al. | May 2006 | B2 |
7053252 | Boussand et al. | May 2006 | B2 |
7057081 | Allison et al. | Jun 2006 | B2 |
7060865 | Ding et al. | Jun 2006 | B2 |
7064238 | Waycuilis | Jun 2006 | B2 |
7064240 | Ohno et al. | Jun 2006 | B2 |
7067448 | Weitkamp et al. | Jun 2006 | B1 |
7083714 | Elomari | Aug 2006 | B2 |
7084308 | Stauffer | Aug 2006 | B1 |
7091270 | Zilberman et al. | Aug 2006 | B2 |
7091387 | Fong et al. | Aug 2006 | B2 |
7091391 | Stauffer | Aug 2006 | B2 |
7094936 | Owens et al. | Aug 2006 | B1 |
7098371 | Mack et al. | Aug 2006 | B2 |
7105710 | Boons et al. | Sep 2006 | B2 |
7138534 | Forlin et al. | Nov 2006 | B2 |
7141708 | Marsella et al. | Nov 2006 | B2 |
7145045 | Harmsen et al. | Dec 2006 | B2 |
7148356 | Smith, III et al. | Dec 2006 | B2 |
7148390 | Zhou et al. | Dec 2006 | B2 |
7151199 | Martens et al. | Dec 2006 | B2 |
7161050 | Sherman et al. | Jan 2007 | B2 |
7169730 | Ma et al. | Jan 2007 | B2 |
7176340 | Van Broekhoven et al. | Feb 2007 | B2 |
7176342 | Bellussi et al. | Feb 2007 | B2 |
7182871 | Perriello | Feb 2007 | B2 |
7193093 | Murray et al. | Mar 2007 | B2 |
7196239 | Van Egmond et al. | Mar 2007 | B2 |
7199083 | Zevallos | Apr 2007 | B2 |
7199255 | Murray et al. | Apr 2007 | B2 |
7208641 | Nagasaki et al. | Apr 2007 | B2 |
7214750 | McDonald et al. | May 2007 | B2 |
7220391 | Huang et al. | May 2007 | B1 |
7226569 | Elomari | Jun 2007 | B2 |
7226576 | Elomari | Jun 2007 | B2 |
7230150 | Grosso et al. | Jun 2007 | B2 |
7230151 | Martens et al. | Jun 2007 | B2 |
7232872 | Shaffer et al. | Jun 2007 | B2 |
7238846 | Janssen et al. | Jul 2007 | B2 |
7244795 | Agapiou et al. | Jul 2007 | B2 |
7244867 | Waycuilis | Jul 2007 | B2 |
7250107 | Benazzi et al. | Jul 2007 | B2 |
7250542 | Smith, Jr. et al. | Jul 2007 | B2 |
7252920 | Kurokawa et al. | Aug 2007 | B2 |
7253327 | Janssens et al. | Aug 2007 | B2 |
7253328 | Stauffer | Aug 2007 | B2 |
7265193 | Weng et al. | Sep 2007 | B2 |
7267758 | Benazzi et al. | Sep 2007 | B2 |
7268263 | Frey et al. | Sep 2007 | B1 |
7271303 | Sechrist et al. | Sep 2007 | B1 |
7273957 | Bakshi et al. | Sep 2007 | B2 |
7282603 | Richards | Oct 2007 | B2 |
7285698 | Liu et al. | Oct 2007 | B2 |
7304193 | Frey et al. | Dec 2007 | B1 |
7342144 | Kaizik et al. | Mar 2008 | B2 |
7348295 | Zones et al. | Mar 2008 | B2 |
7348464 | Waycuilis | Mar 2008 | B2 |
7357904 | Zones et al. | Apr 2008 | B2 |
7361794 | Grosso | Apr 2008 | B2 |
7390395 | Elomari | Jun 2008 | B2 |
20020102672 | Mizrahi | Aug 2002 | A1 |
20020198416 | Zhou et al. | Dec 2002 | A1 |
20030004380 | Grumann | Jan 2003 | A1 |
20030065239 | Zhu | Apr 2003 | A1 |
20030069452 | Sherman et al. | Apr 2003 | A1 |
20030078456 | Yilmaz et al. | Apr 2003 | A1 |
20030120121 | Sherman et al. | Jun 2003 | A1 |
20030125589 | Grosso | Jul 2003 | A1 |
20030166973 | Zhou et al. | Sep 2003 | A1 |
20040006246 | Sherman et al. | Jan 2004 | A1 |
20040062705 | Leduc | Apr 2004 | A1 |
20040152929 | Clarke | Aug 2004 | A1 |
20040158107 | Aoki | Aug 2004 | A1 |
20040158108 | Snoble | Aug 2004 | A1 |
20040187684 | Elomari | Sep 2004 | A1 |
20050047927 | Lee et al. | Mar 2005 | A1 |
20050148805 | Jones | Jul 2005 | A1 |
20050171393 | Lorkovic | Aug 2005 | A1 |
20050192468 | Sherman et al. | Sep 2005 | A1 |
20050215837 | Hoffpauir | Sep 2005 | A1 |
20050234276 | Waycuilis | Oct 2005 | A1 |
20050245772 | Fong | Nov 2005 | A1 |
20050245777 | Fong | Nov 2005 | A1 |
20050267224 | Herling | Dec 2005 | A1 |
20060025617 | Begley | Feb 2006 | A1 |
20060100469 | Waycuilis | May 2006 | A1 |
20060135823 | Jun | Jun 2006 | A1 |
20060138025 | Zones | Jun 2006 | A1 |
20060138026 | Chen | Jun 2006 | A1 |
20060149116 | Slaugh | Jul 2006 | A1 |
20060229228 | Komon et al. | Oct 2006 | A1 |
20060229475 | Weiss et al. | Oct 2006 | A1 |
20060270863 | Reiling | Nov 2006 | A1 |
20060288690 | Elomari | Dec 2006 | A1 |
20070004955 | Kay | Jan 2007 | A1 |
20070078285 | Dagle | Apr 2007 | A1 |
20070100189 | Stauffer | May 2007 | A1 |
20070129584 | Basset | Jun 2007 | A1 |
20070142680 | Ayoub | Jun 2007 | A1 |
20070148067 | Zones | Jun 2007 | A1 |
20070148086 | Zones | Jun 2007 | A1 |
20070149778 | Zones | Jun 2007 | A1 |
20070149789 | Zones | Jun 2007 | A1 |
20070149819 | Zones | Jun 2007 | A1 |
20070149824 | Zones | Jun 2007 | A1 |
20070149837 | Zones | Jun 2007 | A1 |
20070197801 | Bolk | Aug 2007 | A1 |
20070197847 | Liu | Aug 2007 | A1 |
20070213545 | Bolk | Sep 2007 | A1 |
20070238905 | Arredondo | Oct 2007 | A1 |
20070238909 | Gadewar et al. | Oct 2007 | A1 |
20070251382 | Gadewar | Nov 2007 | A1 |
20070276168 | Garel | Nov 2007 | A1 |
20070284284 | Zones | Dec 2007 | A1 |
20080171898 | Waycuilis | Jul 2008 | A1 |
20080183022 | Waycuilis | Jul 2008 | A1 |
20080188697 | Lorkovic | Aug 2008 | A1 |
20080314758 | Grosso | Dec 2008 | A1 |
20090069606 | Komon | Mar 2009 | A1 |
20090127163 | Weiss | May 2009 | A1 |
20100096588 | Gadewar | Apr 2010 | A1 |
20100099928 | Gadewar | Apr 2010 | A1 |
20100099929 | Gadewar | Apr 2010 | A1 |
20100099930 | Stoimenov | Apr 2010 | A1 |
20100105972 | Lorkovic | Apr 2010 | A1 |
20100121119 | Sherman | May 2010 | A1 |
Number | Date | Country |
---|---|---|
0210054 | Aug 2004 | BR |
1099656 | Apr 1981 | CA |
1101441 | May 1981 | CA |
1202610 | Apr 1986 | CA |
2447761 | Nov 2002 | CA |
2471295 | Jul 2003 | CA |
2542857 | May 2005 | CA |
2236126 | Aug 2006 | CA |
2203115 | Sep 2006 | CA |
2510093 | Dec 2006 | CA |
0021497 | Jan 1981 | EP |
0164798 | Dec 1985 | EP |
0418971 | Mar 1991 | EP |
0418974 | Mar 1991 | EP |
0418975 | Mar 1991 | EP |
0510238 | Oct 1992 | EP |
0526908 | Feb 1993 | EP |
0346612 | Aug 1993 | EP |
0560546 | Sep 1993 | EP |
0976705 | Jul 1998 | EP |
1186591 | Mar 2002 | EP |
1253126 | Oct 2002 | EP |
1312411 | May 2003 | EP |
1395536 | Mar 2004 | EP |
1404636 | Apr 2004 | EP |
1235769 | May 2004 | EP |
1435349 | Jul 2004 | EP |
1440939 | Jul 2004 | EP |
1474371 | Nov 2004 | EP |
1235772 | Jan 2005 | EP |
1661620 | May 2006 | EP |
1760057 | Mar 2007 | EP |
1689728 | Apr 2007 | EP |
1808227 | Jul 2007 | EP |
1837320 | Sep 2007 | EP |
5125 | Feb 1912 | GB |
156122 | Mar 1922 | GB |
294100 | Jun 1929 | GB |
363009 | Dec 1931 | GB |
402928 | Dec 1933 | GB |
474922 | Nov 1937 | GB |
536491 | May 1941 | GB |
553950 | Jun 1943 | GB |
586483 | Mar 1947 | GB |
775590 | May 1957 | GB |
793214 | Apr 1958 | GB |
796048 | Jun 1958 | GB |
796085 | Jun 1958 | GB |
883256 | Nov 1961 | GB |
950975 | Mar 1964 | GB |
950976 | Mar 1964 | GB |
991303 | May 1965 | GB |
995960 | Jun 1965 | GB |
1015033 | Dec 1965 | GB |
1104294 | Feb 1968 | GB |
1133752 | Nov 1968 | GB |
1172002 | Nov 1969 | GB |
1212240 | Nov 1970 | GB |
1233299 | May 1971 | GB |
1253618 | Nov 1971 | GB |
1263806 | Feb 1972 | GB |
1446803 | Aug 1976 | GB |
1542112 | Mar 1979 | GB |
2095243 | Sep 1982 | GB |
2095245 | Sep 1982 | GB |
2095249 | Sep 1982 | GB |
2116546 | Sep 1982 | GB |
2120249 | Nov 1983 | GB |
2185754 | Jul 1987 | GB |
2191214 | Dec 1987 | GB |
2004-529189 | Sep 2004 | JP |
8300859 | Mar 1983 | WO |
8504863 | Nov 1985 | WO |
8504867 | Nov 1985 | WO |
9008120 | Jul 1990 | WO |
9008752 | Aug 1990 | WO |
9118856 | Dec 1991 | WO |
9203401 | Mar 1992 | WO |
9212946 | Aug 1992 | WO |
9316798 | Sep 1993 | WO |
9622263 | Jul 1996 | WO |
9744302 | Nov 1997 | WO |
9812165 | Mar 1998 | WO |
9907443 | Feb 1999 | WO |
0007718 | Feb 2000 | WO |
0009261 | Feb 2000 | WO |
0114300 | Mar 2001 | WO |
0138275 | May 2001 | WO |
0144149 | Jun 2001 | WO |
02094749 | Nov 2002 | WO |
02094750 | Nov 2002 | WO |
02094751 | Nov 2002 | WO |
02094752 | Nov 2002 | WO |
03000635 | Jan 2003 | WO |
03002251 | Jan 2003 | WO |
03018524 | Mar 2003 | WO |
03020676 | Mar 2003 | WO |
03022827 | Mar 2003 | WO |
03043575 | May 2003 | WO |
03051813 | Jun 2003 | WO |
03062143 | Jul 2003 | WO |
03062172 | Jul 2003 | WO |
03078366 | Sep 2003 | WO |
2004018093 | Mar 2004 | WO |
2004067487 | Aug 2004 | WO |
2005014168 | Feb 2005 | WO |
2005019143 | Mar 2005 | WO |
2005021468 | Mar 2005 | WO |
2005021468 | Mar 2005 | WO |
2005035121 | Apr 2005 | WO |
2005037758 | Apr 2005 | WO |
2005054120 | Jun 2005 | WO |
2005056525 | Jun 2005 | WO |
2005058782 | Jun 2005 | WO |
2005090272 | Sep 2005 | WO |
2005095310 | Oct 2005 | WO |
2005105709 | Nov 2005 | WO |
2005105715 | Nov 2005 | WO |
2005110953 | Nov 2005 | WO |
2005113437 | Dec 2005 | WO |
2005113440 | Dec 2005 | WO |
2006007093 | Jan 2006 | WO |
2006015824 | Feb 2006 | WO |
2006019399 | Feb 2006 | WO |
2006020234 | Feb 2006 | WO |
2006036293 | Apr 2006 | WO |
2006039213 | Apr 2006 | WO |
2006039354 | Apr 2006 | WO |
2006043075 | Apr 2006 | WO |
2006053345 | May 2006 | WO |
2006-067155 | Jun 2006 | WO |
2006067188 | Jun 2006 | WO |
2006067190 | Jun 2006 | WO |
2006067191 | Jun 2006 | WO |
2006067192 | Jun 2006 | WO |
2006067193 | Jun 2006 | WO |
2006069107 | Jun 2006 | WO |
2006071354 | Jul 2006 | WO |
2006076942 | Jul 2006 | WO |
2006083427 | Aug 2006 | WO |
2006-100312 | Sep 2006 | WO |
2006104909 | Oct 2006 | WO |
2006104914 | Oct 2006 | WO |
2006104914 | Oct 2006 | WO |
2006111997 | Oct 2006 | WO |
2006113205 | Oct 2006 | WO |
2006118935 | Nov 2006 | WO |
2007001934 | Jan 2007 | WO |
2007017900 | Feb 2007 | WO |
2007044139 | Apr 2007 | WO |
2007046986 | Apr 2007 | WO |
2007050745 | May 2007 | WO |
2007071046 | Jun 2007 | WO |
2007079038 | Jul 2007 | WO |
2007091009 | Aug 2007 | WO |
2007094995 | Aug 2007 | WO |
2007107031 | Sep 2007 | WO |
2007111997 | Oct 2007 | WO |
2007114479 | Oct 2007 | WO |
2007125332 | Nov 2007 | WO |
2007130054 | Nov 2007 | WO |
2007130055 | Nov 2007 | WO |
2007141295 | Dec 2007 | WO |
2007142745 | Dec 2007 | WO |
2008036562 | Mar 2008 | WO |
2008036563 | Mar 2008 | WO |
2008106319 | Sep 2008 | WO |
2008157043 | Dec 2008 | WO |
2008157044 | Dec 2008 | WO |
2008157045 | Dec 2008 | WO |
2008157046 | Dec 2008 | WO |
2008157047 | Dec 2008 | WO |
Number | Date | Country | |
---|---|---|---|
20080269534 A1 | Oct 2008 | US |
Number | Date | Country | |
---|---|---|---|
60487364 | Jul 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 10893418 | Jul 2004 | US |
Child | 12217311 | US |